Artículos Científicos

Editor: NOEL GONZÁLEZ GOTERA Número 097 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 170713 – 230813 oto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre el 17 y el 23 de agosto de 2013. Con “vaccin*” en título: 96 artículos recuperados.

Vacunas Meningococo (Neisseria meningitidis)

31. Bactericidal Antibody Persistence Two Years Following Immunization with Two Investigational Serogroup B Meningococcal Vaccines at 6, 8 And 12 Months and Immunogenicity of Pre-School Booster Doses: A Follow-On Study to a Randomized Clinical Trial.

Snape MD, Philip J, John TM, Robinson H, Kelly S, Gossger N, Yu LM, Kittel C, Toneatto D, Dull PM, Pollard AJ.

Pediatr Infect Dis J. 2013 Aug 16. [Epub ahead of print]

PMID: 23958808 [PubMed - as supplied by publisher] Select item 23957483

54. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.

Frosi G, Biolchi A, Sapio ML, Rigat F, Gilchrist S, Lucidarme J, Findlow J, Borrow R, Pizza M, Giuliani MM, Medini D.

Vaccine. 2013 Aug 14. doi:pii: S0264-410X(13)01090-6. 10.1016/j.vaccine.2013.08.006. [Epub ahead of print]

PMID:

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

Vacunas Neumococo (Streptococcus pneumoniae)

1. Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults.

Haas KM, Blevins MW, High KP, Pang B, Swords WE, Yammani RD.

J Infect Dis. 2013 Aug 20. [Epub ahead of print]

PMID: 23964109 [PubMed - as supplied by publisher] Select item 23964090

5. Impact of Pneumococcal Conjugate Vaccines on Microbial Epidemiology and Clinical Outcomes of Acute Otitis Media.

Hau I, Levy C, Caeymaex L, Cohen R.

Paediatr Drugs. 2013 Aug 21. [Epub ahead of print]

PMID: 23963858 [PubMed - as supplied by publisher] Select item 23963730

53. Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.

Vaccine. 2013 Aug 14. doi:pii: S0264-410X(13)01086-4. 10.1016/j.vaccine.2013.08.002. [Epub ahead of print]

PMID: 23954381 [PubMed - as supplied by publisher]

Select item 23954380 23954380 [PubMed - as supplied by publisher] Select item 23954379

93. Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey.

Türel O, Kisa A, McIntosh ED, Bakir M.

Value Health. 2013 Jul-Aug;16(5):755-9. doi: 10.1016/j.jval.2013.03.1632. Epub 2013 Jul 10.

PMID: 23947968 [PubMed - in process] Select item 23947360

54. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.

Frosi G, Biolchi A, Sapio ML, Rigat F, Gilchrist S, Lucidarme J, Findlow J, Borrow R, Pizza M, Giuliani MM, Medini D.

Vaccine. 2013 Aug 14. doi:pii: S0264-410X(13)01090-6. 10.1016/j.vaccine.2013.08.006. [Epub ahead of print]

PMID:

96. [Case report; a recurrent case of fulminant pneumococcal infection due to splenic hypoplasia under use of pneumococcal vaccine].

Utsugi M, Tomizawa M, Matsuzaki S, Maruta S.

Nihon Naika Gakkai Zasshi. 2013 Jun 10;102(6):1470-3. Japanese. No abstract available.

PMID: 23947217 [PubMed - in process]

Vacunas Fiebre tifoidea (Salmonella typhi)

Vacuna Tosferina (Bordetella pertussis)

37. Reduced Risk of Pertussis in Whole-Cell Compared to Acellular Vaccine Recipients is Not Supported When Data Are Stratified by Age.

André P, Johnson DR, Greenberg DP, Decker MD.

Clin Infect Dis. 2013 Aug 15. [Epub ahead of print] No abstract available.

PMID: 23956165 [PubMed - as supplied by publisher] Select item 23956116

Vacuna Tuberculosis (Mycobacterium tuberculosis)

26. Mucosal Vaccination against TB Using Inert Bioparticles.

Reljic R, Sibley L, Huang JM, Pepponi I, Hoppe A, Hong HA, Cutting SM.

Infect Immun. 2013 Aug 19. [Epub ahead of print]

PMID: 23959722 [PubMed - as supplied by publisher] Select item 23959279

Vacunas Cólera (Vibrio cholerae)

40. Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 Serotype Ogawa with emphasis on antigenic density and chain length.

Ftacek P, Nelson V, Szu SC.

Glycoconj J. 2013 Aug 17. [Epub ahead of print]

PMID: 23955520 [PubMed - as supplied by publisher]

Select item 23955431

Adyuvantes

23. Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

Sivakumar SM, Safhi MM, Kannadasan M, Sukumaran N.

Saudi Pharm J. 2011 Oct;19(4):197-206. doi: 10.1016/j.jsps.2011.06.003. Epub 2011 Jun 25.

PMID: 23960760 [PubMed] Select item 23959975

Vacunas, otras

1. Aging promotes B-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: implications for vaccine protection in older adults.

Haas KM, Blevins MW, High KP, Pang B, Swords WE, Yammani RD.

J Infect Dis. 2013 Aug 20. [Epub ahead of print]

PMID: 23964109 [PubMed - as supplied by publisher]

Select item 23964090 2.

Intussusception Risk and Disease Prevention Associated With Rotavirus Vaccines in Australia's National Immunisation Program.

Carlin JB, Macartney K, Lee KJ, Quinn HE, Buttery J, Lopert R, Bines J, McIntyre P.

Clin Infect Dis. 2013 Aug 19. [Epub ahead of print]

PMID: 23964090 [PubMed - as supplied by publisher]

Select item 23964087 3.

Intussusception and Rotavirus Vaccination - Balancing Risk Against Benefit.

Parashar UD, Orenstein WA.

Clin Infect Dis. 2013 Aug 19. [Epub ahead of print] No abstract available.

PMID: 23964087 [PubMed - as supplied by publisher]

Select item 23964059 4.

Vaccine perceptions among Oregon health care providers.

Bean SJ, Catania JA.

Qual Health Res. 2013 Sep;23(9):1251-66. doi: 10.1177/1049732313501891. Epub 2013 Aug 5.

PMID: 23964059 [PubMed - in process]

Select item 23963858 5.

Impact of Pneumococcal Conjugate Vaccines on Microbial Epidemiology and Clinical Outcomes of Acute Otitis Media.

Hau I, Levy C, Caeymaex L, Cohen R.

Paediatr Drugs. 2013 Aug 21. [Epub ahead of print]

PMID: 23963858 [PubMed - as supplied by publisher]

Select item 23963730 6.

Morphologically Virus-Like Fullerenol Nanoparticles Act as the Dual-Functional Nanoadjuvant for HIV-1 Vaccine.

Xu L, Liu Y, Chen Z, Li W, Liu Y, Wang L, Ma L, Shao Y, Zhao Y, Chen C.

Adv Mater. 2013 Aug 21. doi: 10.1002/adma.201300583. [Epub ahead of print]

PMID: 23963730 [PubMed - as supplied by publisher]

Select item 23963666 7.

HPV vaccination--reaping the rewards of the appliance of science.

[No authors listed]

BMJ. 2013 Aug 20;347:f5129. doi: 10.1136/bmj.f5129. No abstract available.

PMID: 23963666 [PubMed - in process]

Select item 23963585 8.

Constitutive expression of the K-domain of a Vaccinium corymbosum SOC1-like (VcSOC1-K) MADS-box gene is sufficient to promote flowering in tobacco.

Song GQ, Walworth A, Zhao D, Hildebrandt B, Leasia M.

Plant Cell Rep. 2013 Aug 21. [Epub ahead of print]

PMID: 23963585 [PubMed - as supplied by publisher]

Select item 23963259 9.

Current issues in dengue vaccination.

Thomas SJ, Endy TP.

Curr Opin Infect Dis. 2013 Aug 19. [Epub ahead of print]

PMID: 23963259 [PubMed - as supplied by publisher]

Select item 23962742 10.

Acquired immunity and vaccination against infectious pancreatic necrosis virus of salmon.

Munang'andu HM, Mutoloki S, Evensen O.

Dev Comp Immunol. 2013 Aug 17. doi:pii: S0145-305X(13)00220-6. 10.1016/j.dci.2013.08.008. [Epub ahead of print]

PMID: 23962742 [PubMed - as supplied by publisher]

Select item 23962611 11.

Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: Implications for Lyme disease vaccine and diagnostic assay design.

Rhodes DV, Earnhart CG, Mather TN, Meeus PF, Marconi RT.

Vet J. 2013 Aug 17. doi:pii: S1090-0233(13)00342-0. 10.1016/j.tvjl.2013.07.019. [Epub ahead of print]

PMID: 23962611 [PubMed - as supplied by publisher]

Select item 23962537 12.

Immunogenicity and safety of HCV E1E2 peptide vaccine in chronically HCV-infected patients who did not respond to interferon based therapy.

El-Awady MK, Gendy ME, Waked I, Tabll AA, Abd YE, Din NB, Shenawy RE, Allam A, Hussien T, Dawood RM.

Vaccine. 2013 Aug 17. doi:pii: S0264-410X(13)01065-7. 10.1016/j.vaccine.2013.07.074. [Epub ahead of print]

PMID: 23962537 [PubMed - as supplied by publisher]

Select item 23962536 13.

EuSANH workshop "Reasons behind the differences in national vaccination schedules for under-five", European Public Health pre-conference workshop, Malta, 8 November 2012.

Theeten H, Nohynek H, Coenen TM; European Science Advisory Network for Health (EuSANH).

Vaccine. 2013 Aug 17. doi:pii: S0264-410X(13)01098-0. 10.1016/j.vaccine.2013.08.014. [Epub ahead of print]

PMID: 23962536 [PubMed - as supplied by publisher]

Select item 23962535 14.

Effect of abatacept on immunogenicity of vaccines in individuals with type 1 diabetes.

Weinberg A, Boulware D, Dighero B, Orban T; the Type 1 Diabetes TrialNet Abatacept Study Group.

Vaccine. 2013 Aug 17. doi:pii: S0264-410X(13)01084-0. 10.1016/j.vaccine.2013.07.086. [Epub ahead of print]

PMID: 23962535 [PubMed - as supplied by publisher]

Select item 23962534 15.

Towards rationale vaccine policy: A case against inclusion of rabies vaccine into routine national immunization programme in India.

Patil RR.

Vaccine. 2013 Aug 17. doi:pii: S0264-410X(13)01102-X. 10.1016/j.vaccine.2013.08.018. [Epub ahead of print] No abstract available.

PMID: 23962534 [PubMed - as supplied by publisher]

Select item 23962533 16.

Reply to: Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact.

Wassil J, Huels J, Narasimhan V.

Vaccine. 2013 Aug 17. doi:pii: S0264-410X(13)01101-8. 10.1016/j.vaccine.2013.08.017. [Epub ahead of print] No abstract available.

PMID: 23962533 [PubMed - as supplied by publisher]

Select item 23962532 17.

Is there a lack of information on HPV vaccination given by health professionals to young women?

La Torre G, De Vito E, Ficarra MG, Firenze A, Gregorio P, Boccia A; HPV Collaborative Group.

Vaccine. 2013 Aug 17. doi:pii: S0264-410X(13)01099-2. 10.1016/j.vaccine.2013.08.015. [Epub ahead of print]

PMID: 23962532 [PubMed - as supplied by publisher]

Select item 23962282 18.

Construction of KHV-CJ ORF25 DNA vaccine and immune challenge test.

Zhou JX, Wang H, Li XW, Zhu X, Lu WL, Zhang DM.

J Fish Dis. 2013 Aug 21. doi: 10.1111/jfd.12105. [Epub ahead of print]

PMID: 23962282 [PubMed - as supplied by publisher]

Select item 23962071 19.

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.

Warimwe GM, Fletcher HA, Olotu A, Agnandji ST, Hill AV, Marsh K, Bejon P.

BMC Med. 2013 Aug 21;11(1):184. [Epub ahead of print]

PMID: 23962071 [PubMed - as supplied by publisher]

Select item 23962062 20.

Parents who refuse to vaccinate their infants: paediatricians' feelings and treatment intentions.

Maayan-Metzger A, Kedem-Friedrich P, Ben-Namer-Basseches M, Kuint J.

Acta Paediatr. 2013 Aug 20. doi: 10.1111/apa.12397. [Epub ahead of print]

PMID: 23962062 [PubMed - as supplied by publisher]

Select item 23961653 21.

[Development of a vaccine against HIV: is this aim accomplishable?].

Wagner R, Asbach B.

MMW Fortschr Med. 2013 Jun 13;155 Suppl 1:36-9. German. No abstract available.

PMID: 23961653 [PubMed - in process]

Select item 23961396 22.

Non-conventional induction strategies for production of subunit swine erysipelas vaccine antigen in rE. coli fed-batch cultures. da Silva AJ, Horta AC, Velez AM, Iemma MR, Sargo CR, Giordano RL, Novo MT, Giordano RC, Zangirolami TC.

Springerplus. 2013 Jul 17;2:322. doi: 10.1186/2193-1801-2-322.

PMID: 23961396 [PubMed]

Select item 23960760 23.

Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

Sivakumar SM, Safhi MM, Kannadasan M, Sukumaran N.

Saudi Pharm J. 2011 Oct;19(4):197-206. doi: 10.1016/j.jsps.2011.06.003. Epub 2011 Jun 25.

PMID: 23960760 [PubMed]

Select item 23959975 24.

Expert-novice differences in mental models of viruses, vaccines, and the causes of infectious disease.

Jee BD, Uttal DH, Spiegel A, Diamond J.

Public Underst Sci. 2013 Aug 19. [Epub ahead of print]

PMID: 23959975 [PubMed - as supplied by publisher]

Select item 23959795 25.

Treg Vaccination in Autoimmune Type 1 Diabetes.

Serr I, Weigmann B, Franke RK, Daniel C.

BioDrugs. 2013 Aug 20. [Epub ahead of print]

PMID: 23959795 [PubMed - as supplied by publisher]

Select item 23959722 26.

Mucosal Vaccination against TB Using Inert Bioparticles.

Reljic R, Sibley L, Huang JM, Pepponi I, Hoppe A, Hong HA, Cutting SM.

Infect Immun. 2013 Aug 19. [Epub ahead of print]

PMID: 23959722 [PubMed - as supplied by publisher]

Select item 23959279 27.

Hepatitis B virus screening and vaccination in a family from Nigeria.

Rashid M, Greenaway C.

CMAJ. 2013 Aug 19. [Epub ahead of print] No abstract available.

PMID: 23959279 [PubMed - as supplied by publisher]

Select item 23959170 28.

Protective effect of bilberry (Vaccinium myrtillus L.) on cisplatin induced ovarian damage in rat.

Pandir D, Kara O, Kara M.

Cytotechnology. 2013 Aug 20. [Epub ahead of print]

PMID: 23959170 [PubMed - as supplied by publisher]

Select item 23959094 29.

Letter to the editor referring to the manuscript entitled: "Increasing fear of adverse effects drops intention to vaccinate after the introduction of prophylactic HPV vaccine" reported by Sotiriadis et al. (Arch Gynecol Obstet. 2012 Jun;285(6):1719-24).

Chatzistamatiou K, Sotiriadis A, Agorastos T.

Arch Gynecol Obstet. 2013 Aug 20. [Epub ahead of print] No abstract available.

PMID: 23959094 [PubMed - as supplied by publisher]

Select item 23958910 30.

Progress toward Elimination of Hepatitis B Virus Transmission in Oman: Impact of Hepatitis B Vaccination.

Thabit Al Awaidy S, Pandurang Bawikar S, Salim Al Busaidy S, Al Mahrouqi S, Al Baqlani S, Al Obaidani I, Alexander J, Patel MK.

Am J Trop Med Hyg. 2013 Aug 19. [Epub ahead of print]

PMID: 23958910 [PubMed - as supplied by publisher] Free Article

Select item 23958808 31.

Bactericidal Antibody Persistence Two Years Following Immunization with Two Investigational Serogroup B Meningococcal Vaccines at 6, 8 And 12 Months and Immunogenicity of Pre-School Booster Doses: A Follow-On Study to a Randomized Clinical Trial.

Snape MD, Philip J, John TM, Robinson H, Kelly S, Gossger N, Yu LM, Kittel C, Toneatto D, Dull PM, Pollard AJ.

Pediatr Infect Dis J. 2013 Aug 16. [Epub ahead of print]

PMID: 23958808 [PubMed - as supplied by publisher]

Select item 23957483 32.

Influenza vaccination rate among patients with moderate to severe psoriasis.

Radtke MA, Rustenbach SJ, Reusch M, Strömer K, Augustin M.

J Dtsch Dermatol Ges. 2013 Sep;11(9):837-44. doi: 10.1111/ddg.12010.

PMID: 23957483 [PubMed - in process]

Select item 23956612 33. 11

Multicenter Study of Human Papillomavirus and the Human Papillomavirus Vaccine: Knowledge and Attitudes among People of African Descent.

Blackman E, Thurman N, Halliday D, Butler R, Francis D, Joseph M, Thompson J, Akers A, Andraos-Selim C, Bondzi C, Taioli E, Hagan KL, Jones EA, Jones J, Moss CM, Smith AC, Ashing KT, Ragin CC.

Infect Dis Obstet Gynecol. 2013;2013:428582. doi: 10.1155/2013/428582. Epub 2013 Jul 16.

PMID: 23956612 [PubMed - in process] Free Article

Select item 23956431 34.

DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza.

Grodeland G, Mjaaland S, Roux KH, Fredriksen AB, Bogen B.

J Immunol. 2013 Aug 16. [Epub ahead of print]

PMID: 23956431 [PubMed - as supplied by publisher]

Select item 23956243 35.

A Whole-Genome Analysis of a Transgenic Rice Seed-Based Edible Vaccine Against Cedar Pollen Allergy.

Kawakatsu T, Kawahara Y, Itoh T, Takaiwa F.

DNA Res. 2013 Aug 15. [Epub ahead of print]

PMID: 23956243 [PubMed - as supplied by publisher]

Select item 23956169 36.

Effectiveness of non-adjuvanted monovalent A(H1N1)pdm09 vaccines for preventing RT-PCR-confirmed pandemic influenza hospitalizations: Case-control study of children and adults at ten U.S. Influenza Surveillance Network sites.

Thompson M, Sokolow LZ, Almendares O, Openo K, Farley MM, Meek J, Ray J, Kirley PD, Reingold A, Aragon D, Hancock E, Baumbach J, Schaffner W, Lynfield R, Ryan P, Monroe M, Cheng PY, Fry A, Shay DK.

Clin Infect Dis. 2013 Aug 15. [Epub ahead of print]

PMID: 23956169

[PubMed - as supplied by publisher]

Select item 23956165 37.

Reduced Risk of Pertussis in Whole-Cell Compared to Acellular Vaccine Recipients is Not Supported When Data Are Stratified by Age.

André P, Johnson DR, Greenberg DP, Decker MD.

Clin Infect Dis. 2013 Aug 15. [Epub ahead of print] No abstract available.

PMID: 23956165 [PubMed - as supplied by publisher]

Select item 23956116 38.

A novel recombinant Salmonella vaccine enhances the innate immunity of NK cells against acute myeloid leukaemia cells Kasumi-1 in vitro.

Zhang B, Liu Y, Wang X, Jiang L, Lu Z, Zhang X, Li K, Hu H.

Cell Biol Int. 2013 Aug 19. doi: 10.1002/cbin.10173. [Epub ahead of print]

PMID: 23956116 [PubMed - as supplied by publisher]

Select item 23955905 39.

A Novel Adjuvant, Mixture of Alum And Naltrexone, Elicits Humoral Immune Responses for excreted/secreted Antigens of Toxoplasma gondii Tachyzoites Vaccine In Balb/c Murine Model.

Tappeh KH, Khorshidvand Z, Shahabi S, Mohammadzadeh H.

Turkiye Parazitol Derg. 2013;37(2):92-96. doi: :10.5152/tpd.2013.22.

PMID: 23955905 [PubMed - as supplied by publisher] Free Article

Select item 23955520 40.

Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 Serotype Ogawa with emphasis on antigenic density and chain length.

Ftacek P, Nelson V, Szu SC.

Glycoconj J. 2013 Aug 17. [Epub ahead of print]

PMID: 23955520

[PubMed - as supplied by publisher]

Select item 23955431 41.

Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults.

Creech CB, Dekker CL, Ho D, Phillips S, Mackey S, Murray-Krezan C, Grazia Pau M, Hendriks J, Brown V, Dally LG, Versteege I, Edwards KM.

Hum Vaccin Immunother. 2013 Aug 17;9(12). [Epub ahead of print]

PMID: 23955431 [PubMed - as supplied by publisher]

Select item 23955378 42.

Effectiveness of one dose of mumps vaccine against clinically diagnosed mumps in Guangzhou, China, 2006-2012.

Fu C, Xu J, Cai Y, He Q, Zhang C, Chen J, Dong Z, Hu W, Wang H, Zhu W, Wang M.

Hum Vaccin Immunother. 2013 Aug 16;9(12). [Epub ahead of print]

PMID: 23955378 [PubMed - as supplied by publisher]

Select item 23955319 43.

Advances in the study of HLA-restricted epitope vaccines.

Zhao L, Zhang M, Cong H.

Hum Vaccin Immunother. 2013 Aug 16;9(12). [Epub ahead of print]

PMID: 23955319 [PubMed - as supplied by publisher]

Select item 23955280 44.

Infection-enhancing lipopeptides do not improve intranasal immunization of cotton rats with a delta-G candidate live-attenuated human respiratory syncytial virus vaccine.

Tien Nguyen D, Boes J, van Amerongen G, van Remmerden Y, Yüksel S, Guichelaar T, Osterhaus AD, de Swart RL.

Hum Vaccin Immunother. 2013 Aug 16;9(12). [Epub ahead of print]

PMID: 23955280 [PubMed - as supplied by publisher]

Select item 23955246 45.

Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia.

Nelson EA, de Quadros CA, Santosham M, Parashar UD, Steele D.

Hum Vaccin Immunother. 2013 Aug 16;9(11). [Epub ahead of print]

PMID: 23955246 [PubMed - as supplied by publisher]

Select item 23955057 46.

Protein carriers of conjugate vaccines: Characteristics, development and clinical trials.

Pichichero ME.

Hum Vaccin Immunother. 2013 Aug 16;9(12). [Epub ahead of print]

PMID: 23955057 [PubMed - as supplied by publisher]

Select item 23954990 47.

Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy.

Bonaccorsi G, Lorini C, Santomauro F, Guarducci S, Pellegrino E, Puggelli F, Balli M, Bonanni P.

Hum Vaccin Immunother. 2013 Aug 16;9(12). [Epub ahead of print]

PMID: 23954990 [PubMed - as supplied by publisher]

Select item 23954979 48.

Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.

Kichaev G, Mendoza JM, Amante D, Smith TR, McCoy JR, Sardesai NY, Broderick KE.

Hum Vaccin Immunother. 2013 Jun 11;9(10). [Epub ahead of print]

PMID: 23954979 [PubMed - as supplied by publisher]

Select item 23954670 49.

Targeted vaccination programme successful in reducing acute Hepatitis B in men having sex with men in Amsterdam, The Netherlands.

Rijckevorsel GV, Whelan J, Kretzschmar M, Siedenburg E, Sonder G, Geskus R, Coutinho R, Hoek AV.

J Hepatol. 2013 Aug 13. doi:pii: S0168-8278(13)00555-2. 10.1016/j.jhep.2013.08.002. [Epub ahead of print]

PMID: 23954670 [PubMed - as supplied by publisher]

Select item 23954582 50.

Intravaginal and subcutaneous immunization induced vaccine-specific CD8 T-cells and tumor-regression in the bladder.

Domingos-Pereira S, Derré L, Warpelin-Decrausaz L, Haefliger JA, Romero P, Jichlinski P, Nardelli-Haefliger D.

J Urol. 2013 Aug 13. doi:pii: S0022-5347(13)05123-9. 10.1016/j.juro.2013.08.009. [Epub ahead of print]

PMID: 23954582 [PubMed - as supplied by publisher]

Select item 23954384 51.

SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12.

Lindsay RW, Ouellette I, Arendt HE, Martinez J, Destefano J, Lopez M, Pavlakis GN, Chiuchiolo MJ, Parks CL, King CR.

Vaccine. 2013 Aug 14. doi:pii: S0264-410X(13)01095-5. 10.1016/j.vaccine.2013.08.011. [Epub ahead of print]

PMID: 23954384 [PubMed - as supplied by publisher]

Select item 23954383 52.

The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.

Weinberger EE, Isakovic A, Scheiblhofer S, Ramsauer C, Reiter K, Hauser-Kronberger C, Thalhamer J, Weiss R.

Vaccine. 2013 Aug 14. doi:pii: S0264-410X(13)01089-X. 10.1016/j.vaccine.2013.08.005. [Epub ahead of print] 16

PMID: 23954383 [PubMed - as supplied by publisher]

Select item 23954381

Abzug MJ, Song LY, Levin MJ, Nachman SA, Borkowsky W, Pelton SI; for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams. 53.

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.

Vaccine. 2013 Aug 14. doi:pii: S0264-410X(13)01086-4. 10.1016/j.vaccine.2013.08.002. [Epub ahead of print]

PMID: 23954381 [PubMed - as supplied by publisher]

Select item 23954380 23954380 [PubMed - as supplied by publisher] Select item 23954379 54. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.

Frosi G, Biolchi A, Sapio ML, Rigat F, Gilchrist S, Lucidarme J, Findlow J, Borrow R, Pizza M, Giuliani MM, Medini D.

Vaccine. 2013 Aug 14. doi:pii: S0264-410X(13)01090-6. 10.1016/j.vaccine.2013.08.006. [Epub ahead of print]

PMID:

55.

Associations between health communication behaviors, neighborhood social capital, vaccine knowledge, and parents' H1N1 vaccination of their children.

Jung M, Lin L, Viswanath K.

Vaccine. 2013 Aug 14. doi:pii: S0264-410X(13)01054-2. 10.1016/j.vaccine.2013.07.068. [Epub ahead of print]

PMID: 23954379 [PubMed - as supplied by publisher]

Select item 23954198 56.

Synthesis of novel lipidated iridoid glycosides as vaccine adjuvants: 6-O-Palmitoyl Agnuside elicit strong Th1 and Th2 response to ovalbumin in mice.

Singh PP, Bhunia D, Verma YK, Sidiq T, Khajuria A, Gupta A, Pallavi MP, Vamshi SS, Qazi GN, Kumar HM.

Int Immunopharmacol. 2013 Aug 14. doi:pii: S1567-5769(13)00303-2. 10.1016/j.intimp.2013.07.018. [Epub ahead of print]

PMID: 23954198 [PubMed - as supplied by publisher]

Select item 23953913 57.

HPV vaccination coverage in French girls attending middle and high schools: a declarative cross sectional study in the department of Côte d'Or.

Bertaut A, Chavanet P, Aho S, Astruc K, Douvier S, Fournel I.

Eur J Obstet Gynecol Reprod Biol. 2013 Aug 14. doi:pii: S0301-2115(13)00335-7. 10.1016/j.ejogrb.2013.07.028. [Epub ahead of print]

PMID: 23953913 [PubMed - as supplied by publisher]

Select item 23953841 58.

The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation.

Chen J, Pompano RR, Santiago FW, Maillat L, Sciammas R, Sun T, Han H, Topham DJ, Chong AS, Collier JH.

Biomaterials. 2013 Aug 13. doi:pii: S0142-9612(13)00877-6. 10.1016/j.biomaterials.2013.07.063. [Epub ahead of print]

PMID: 23953841 [PubMed - as supplied by publisher]

Select item 23953808 59.

Variability in the immune system: of vaccine responses and immune states.

Shen-Orr SS, Furman D.

Curr Opin Immunol. 2013 Aug 13. doi:pii: S0952-7915(13)00113-1. 10.1016/j.coi.2013.07.009. [Epub ahead of print]

PMID: 23953808 [PubMed - as supplied by publisher]

Select item 23953764 60.

Is the MMR vaccination programme failing to protect women against rubella infection?

Skidmore S, Boxall E, Lord S.

Epidemiol Infect. 2013 Aug 19:1-4. [Epub ahead of print]

PMID: 23953764 [PubMed - as supplied by publisher]

Select item 23953581 61.

Cyclosporine combined with nonlytic interleukin 2/fc fusion protein improves immune response to hepatitis B vaccination in a mouse skin transplantation model.

Li Z, Zhang D, Gao J, Li WX, Zhu JY.

Transplant Proc. 2013 Jul-Aug;45(6):2559-64. doi: 10.1016/j.transproceed.2013.02.123.

PMID: 23953581 [PubMed - in process]

Select item 23953356 62.

Evaluating a standardized measure of healthcare personnel influenza vaccination.

Lindley MC, Lorick SA, Geevarughese A, Lee SJ, Makvandi M, Miller BL, Nace DA, Smith C, Ahmed F.

Am J Prev Med. 2013 Sep;45(3):297-303. doi: 10.1016/j.amepre.2013.04.019.

PMID: 23953356 [PubMed - in process]

Select item 23952836 63.

Mandatory influenza vaccination: how far to go and whom to target without evidence?

Pipon JC, Frenette M.

Am J Bioeth. 2013 Sep;13(9):48-50. doi: 10.1080/15265161.2013.813607. No abstract available.

PMID: 23952836 [PubMed - in process]

Select item 23952835 64.

Evidence and ethics in mandatory vaccination policies.

Schwartz JL.

Am J Bioeth. 2013 Sep;13(9):46-8. doi: 10.1080/15265161.2013.815023. No abstract available.

PMID: 23952835 [PubMed - in process]

Select item 23952834 65.

Exemptions from influenza vaccinations for health care personnel based on self or identity issues: are they justified?

Trafimow D.

Am J Bioeth. 2013 Sep;13(9):44-6. doi: 10.1080/15265161.2013.813598. No abstract available.

PMID: 23952834 [PubMed - in process]

Select item 23952832 66.

Guidance from vaccination jurisprudence.

Ulrich MR.

Am J Bioeth. 2013 Sep;13(9):40-2. doi: 10.1080/15265161.2013.813608. No abstract available.

PMID: 23952832 [PubMed - in process]

Select item 23952831 67.

The case for mandatory flu vaccination of children.

Bambery B, Selgelid M, Maslen H, Pollard AJ, Savulescu J.

Am J Bioeth. 2013 Sep;13(9):38-40. doi: 10.1080/15265161.2013.813602. No abstract available.

PMID: 23952831 [PubMed - in process]

Select item 23952830 68.

An ethical analysis of mandatory influenza vaccination of health care personnel: implementing fairly and balancing benefits and burdens.

Matheny Antommaria AH.

Am J Bioeth. 2013 Sep;13(9):30-7. doi: 10.1080/15265161.2013.814731.

PMID: 23952830 [PubMed - in process]

Select item 23952821 69.

Vaccine mandates are justifiable because we are all in this together.

Lantos JD, Jackson MA.

Am J Bioeth. 2013 Sep;13(9):1-2. doi: 10.1080/15265161.2013.815021. No abstract available.

PMID: 23952821 [PubMed - in process]

Select item 23952481 70.

Low hepatitis B vaccine response in children with Down syndrome from Brazil.

Nisihara R, De Bem RS, Negreiros PH, Utiyama SR, Oliveira NP, Amarante H.

Child Care Health Dev. 2013 Aug 19. doi: 10.1111/cch.12099. [Epub ahead of print]

PMID: 23952481 [PubMed - as supplied by publisher]

Select item 23951373 71.

The effect of vaccination coverage and climate on Japanese encephalitis in sarawak, malaysia.

Impoinvil DE, Ooi MH, Diggle PJ, Caminade C, Cardosa MJ, Morse AP, Baylis M, Solomon T.

PLoS Negl Trop Dis. 2013 Aug 8;7(8):e2334. doi: 10.1371/journal.pntd.0002334.

PMID: 23951373 [PubMed - in process] Free Article

Select item 23951355 72.

A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.

Wennier ST, Brinkmann K, Steinhäußer C, Mayländer N, Mnich C, Wielert U, Dirmeier U, Hausmann J, Chaplin P, Steigerwald R.

PLoS One. 2013 Aug 12;8(8):e73511. doi: 10.1371/journal.pone.0073511.

PMID:

23951355 [PubMed - in process] Free Article

Select item 23951151 73.

Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination.

Moss AJ, Gaughran FP, Karasu A, Gilbert AS, Mann AJ, Gelder CM, Oxford JS, Stephens HA, Lambkin-Williams R.

PLoS One. 2013 Aug 9;8(8):e71376. doi: 10.1371/journal.pone.0071376.

PMID: 23951151 [PubMed - in process] Free Article

Select item 23951135 74.

Bicistronic DNA Vaccines Simultaneously Encoding HIV, HSV and HPV Antigens Promote CD8(+) T Cell Responses and Protective Immunity.

Santana VC, Diniz MO, Cariri FA, Ventura AM, Cunha-Neto E, Almeida RR, Campos MA, Lima GK, Ferreira LC.

PLoS One. 2013 Aug 8;8(8):e71322. doi: 10.1371/journal.pone.0071322.

PMID: 23951135 [PubMed - in process] Free Article

Select item 23951123 75.

Predictors of Three Dose On-Time Compliance with HPV4 Vaccination in a Disadvantaged, Underserved, Safety Net Population in the US Midwest.

Verdenius I, Harper DM, Harris GD, Griffith RS, Wall J, Hempstead LK, Malnar GJ, Bekkers RL.

PLoS One. 2013 Aug 8;8(8):e71295. doi: 10.1371/journal.pone.0071295.

PMID: 23951123 [PubMed - in process] Free Article

Select item 23951084 76.

A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles.

Rigter A, Widjaja I, Versantvoort H, Coenjaerts FE, van Roosmalen M, Leenhouts K, Rottier PJ, Haijema BJ, de Haan CA. 22

PLoS One. 2013 Aug 12;8(8):e71072. doi: 10.1371/journal.pone.0071072.

PMID: 23951084 [PubMed - in process] Free Article

Select item 23951035 77.

Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial. van den Berg JP, Westerbeek EA, van der Klis FR, Berbers GA, Lafeber HN, van Elburg RM.

PLoS One. 2013 Aug 8;8(8):e70904. doi: 10.1371/journal.pone.0070904.

PMID: 23951035 [PubMed - in process] Free Article

Select item 23951015 78.

Protective Efficacy of Baculovirus Dual Expression System Vaccine Expressing Plasmodium falciparum Circumsporozoite Protein.

Iyori M, Nakaya H, Inagaki K, Pichyangkul S, Yamamoto DS, Kawasaki M, Kwak K, Mizukoshi M, Goto Y, Matsuoka H, Matsumoto M, Yoshida S.

PLoS One. 2013 Aug 12;8(8):e70819. doi: 10.1371/journal.pone.0070819.

PMID: 23951015 [PubMed - in process] Free Article

Select item 23950951 79.

Endocine™, N3OA and N3OASq; Three Mucosal Adjuvants That Enhance the Immune Response to Nasal Influenza Vaccination.

Falkeborn T, Bråve A, Larsson M, Akerlind B, Schröder U, Hinkula J.

PLoS One. 2013 Aug 8;8(8):e70527. doi: 10.1371/journal.pone.0070527.

PMID: 23950951 [PubMed - in process] Free Article

Select item 23950909 80.

Evaluation of a Salmonella Vectored Vaccine Expressing Mycobacterium avium Subsp. paratuberculosis Antigens Against Challenge in a Goat Model.

Faisal SM, Yan F, Chen TT, Useh NM, Guo S, Yan W, Wang SJ, Glaser AL, McDonough SP, Singh B, Chang YF.

PLoS One. 2013 Aug 9;8(8):e70171. doi: 10.1371/journal.pone.0070171.

PMID: 23950909 [PubMed - in process] Free Article

Select item 23950869 81.

No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix Vaccination Campaign in Finland.

Melén K, Partinen M, Tynell J, Sillanpää M, Himanen SL, Saarenpää-Heikkilä O, Hublin C, Olsen P, Ilonen J, Nohynek H, Syrjänen R, Kilpi T, Vuorela A, Kirjavainen T, Vaarala O, Julkunen I.

PLoS One. 2013 Aug 8;8(8):e68402. doi: 10.1371/journal.pone.0068402.

PMID: 23950869 [PubMed - in process] Free Article

Select item 23950814 82.

Correction: Influenza Vaccination in Adults with Chronic Obstructive Pulmonary Disease: The Impact of a Diagnostic Breathing Test on Vaccination Rates.

Mowls DS, Cheruvu VK, Zullo MD.

PLoS One. 2013 Jul 18;8(7). doi: 10.1371/annotation/c472fa25-5876-4b8e-bb3d- 4f23e68bb277.

PMID: 23950814 [PubMed - as supplied by publisher] Free Article

Select item 23949514 83.

[Addressing the controversy regarding the association between thimerosal-containing vaccines and autism].

García-Fernández L, Hernández AV, Suárez Moreno V, Fiestas F.

Rev Peru Med Exp Salud Publica. 2013 Jun;30(2):268-74. Spanish.

PMID: 23949514 [PubMed - in process] Free Article

Select item 23949283 84.

Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2.

Aldhamen YA, Seregin SS, Kousa YA, Rastall DP, Appledorn DM, Godbehere S, Schutte BC, Amalfitano A.

Cancer Gene Ther. 2013 Aug 16. doi: 10.1038/cgt.2013.53. [Epub ahead of print]

PMID: 23949283 [PubMed - as supplied by publisher]

Select item 23949265 85.

The Quest for a H1N1 Vaccine.

Matter A.

Ann Acad Med Singapore. 2013 Jul;42(7):354-5. No abstract available.

PMID: 23949265 [PubMed - in process] Free Article

Select item 23948572 86.

Correlates of protection against influenza infection in humans-on the path to a universal vaccine?

Li CK, Rappuoli R, Xu XN.

Curr Opin Immunol. 2013 Aug 12. doi:pii: S0952-7915(13)00109-X. 10.1016/j.coi.2013.07.005. [Epub ahead of print]

PMID: 23948572 [PubMed - as supplied by publisher]

Select item 23948357 87.

Antibody and T cell responses induced in chickens immunized with avian influenza virus N1 and NP DNA vaccine with chicken IL-15 and IL-18.

Lim KL, Jazayeri SD, Yeap SK, Mohamed Alitheen NB, Bejo MH, Ideris A, Omar AR.

Res Vet Sci. 2013 Aug 12. doi:pii: S0034-5288(13)00238-5. 10.1016/j.rvsc.2013.07.013. [Epub ahead of print]

PMID: 23948357 [PubMed - as supplied by publisher]

Select item 23948229 88.

Reprint of: Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination.

Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y.

Vaccine. 2013 Aug 12. doi:pii: S0264-410X(13)01096-7. 10.1016/j.vaccine.2013.08.012. [Epub ahead of print]

PMID: 23948229 [PubMed - as supplied by publisher]

Select item 23948228 89.

Reprint of: Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005.

Cui F, Li L, Hadler SC, Wang F, Zheng H, Chen Y, Gong X, Hutin YJ, Cairns KL, Liang X, Yang W.

Vaccine. 2013 Aug 12. doi:pii: S0264-410X(13)01097-9. 10.1016/j.vaccine.2013.08.013. [Epub ahead of print]

PMID: 23948228 [PubMed - as supplied by publisher]

Select item 23948227 90.

Vaccination with Flt3L-induced CD8α⁺ dendritic cells prevents CD4⁺ T helper cell-mediated experimental autoimmune myocarditis.

Valaperti A, Nishii M, Germano D, Liu PP, Eriksson U.

Vaccine. 2013 Aug 12. doi:pii: S0264-410X(13)01082-7. 10.1016/j.vaccine.2013.07.084. [Epub ahead of print]

PMID: 23948227 [PubMed - as supplied by publisher]

Select item 23948147 91.

Cell-mediated immune responses in the head-associated lymphoid tissues induced to a live attenuated avian coronavirus vaccine.

Gurjar RS, Gulley SL, van Ginkel FW.

Dev Comp Immunol. 2013 Aug 12. doi:pii: S0145-305X(13)00214-0. 10.1016/j.dci.2013.08.002. [Epub ahead of print]

PMID: 23948147 [PubMed - as supplied by publisher]

Select item 23948014 92.

An Assessment of the Performance of Self-Reported Vaccination Status for Hepatitis B, National Health and Nutrition Examination Survey 1999-2008.

Denniston MM, Byrd KK, Klevens RM, Drobeniuc J, Kamili S, Jiles RB.

Am J Public Health. 2013 Aug 15. [Epub ahead of print]

PMID: 23948014 [PubMed - as supplied by publisher]

Select item 23947968 93.

Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey.

Türel O, Kisa A, McIntosh ED, Bakir M.

Value Health. 2013 Jul-Aug;16(5):755-9. doi: 10.1016/j.jval.2013.03.1632. Epub 2013 Jul 10.

PMID: 23947968 [PubMed - in process]

Select item 23947360 94.

Immunity to viruses: learning from successful human vaccines.

Pulendran B, Oh JZ, Nakaya HI, Ravindran R, Kazmin DA.

Immunol Rev. 2013 Sep;255(1):243-55. doi: 10.1111/imr.12099.

PMID: 23947360 [PubMed - in process]

Select item 23947359 95.

Advances in antiviral vaccine development.

Graham BS.

Immunol Rev. 2013 Sep;255(1):230-42. doi: 10.1111/imr.12098.

PMID: 23947359 [PubMed - in process]

Select item 23947217 96.

[Case report; a recurrent case of fulminant pneumococcal infection due to splenic hypoplasia under use of pneumococcal vaccine].

Utsugi M, Tomizawa M, Matsuzaki S, Maruta S.

Nihon Naika Gakkai Zasshi. 2013 Jun 10;102(6):1470-3. Japanese. No abstract available.

PMID: 23947217 [PubMed - in process]

AMEDEO - Vaccines Publicaciones (19 - 08 - 2013): 46 artículos nuevos.

Vacunas Meningococo (Neisseria meningitidis)

20. KUPFERSCHMIDT K. Infectious diseases. Bacterial meningitis finds new niche in gay communities. Science. 2013;341:328. PubMed: www.amedeo.com/p2.php?id=23888010&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/23888010

36. BORROW R, Abad R, Trotter C, van der Klis FR, et al. Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine. 2013 Aug 8. pii: S0264-410X(13)01074. PubMed: www.amedeo.com/p2.php?id=23933336&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933336

Vacunas Neumococo (Streptococcus pneumoniae)

2. MOSZYNSKI P. Refugees in South Sudan to receive pneumococcal vaccine after delays over price. BMJ. 2013;347:f5042. PubMed: www.amedeo.com/p2.php?id=23935063&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/23935063

15. ENGEL ME, Muhamed B, Whitelaw AC, Musvosvi M, et al. Group A Streptococcal emm Type Prevalence among Symptomatic Children in Cape Town and Potential Vaccine Coverage. Pediatr Infect Dis J. 2013. PubMed: www.amedeo.com/p2.php?id=23934204&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23934204

23. GOLDBLATT D, Ramakrishnan M, O'Brien K. Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; A Pneumocarr meeting report March 27-28, 2012, Geneva. Vaccine. 2013 Aug 6. pii: S0264-410X(13)00818. PubMed: www.amedeo.com/p2.php?id=23933374&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933374

Vacunas Fiebre tifoidea (Salmonella typhi)

28. JONES C, Lee CK, Ahn C, Shin J, et al. Working Group on quality, safety and efficacy of typhoid Vi capsular

28 polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012. Vaccine. 2013 Aug 6. pii: S0264-410X(13)01056. PubMed: www.amedeo.com/p2.php?id=23933367&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933367

Vacuna Tosferina (Bordetella pertussis)

30. VAN DER MAAS NA, Mooi FR, de Greeff SC, Berbers GA, et al. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine. 2013 Aug 6. pii: S0264-410X(13)01046. PubMed: www.amedeo.com/p2.php?id=23933365&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933365

Vacuna Tuberculosis (Mycobacterium tuberculosis)

7. LINDENSTROM T, Knudsen NP, Agger EM, Andersen P, et al. Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1- IL-2-Secreting Central Memory Cells. J Immunol. 2013. PubMed: www.amedeo.com/p2.php?id=23677471&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23677471

Vacunas, otras

1. TORJESEN I. Intravenous vaccine shows promise against malaria. BMJ. 2013;347:f5058. PubMed: www.amedeo.com/p2.php?id=23940294&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23940294

2. MOSZYNSKI P. Refugees in South Sudan to receive pneumococcal vaccine after delays over price. BMJ. 2013;347:f5042. PubMed: www.amedeo.com/p2.php?id=23935063&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23935063

3. KMIETOWICZ Z. HPV testing could cut cervical cancers by a third, finds study. BMJ. 2013;346:f3888. PubMed: www.amedeo.com/p2.php?id=23771041&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23771041

4. MEARKLE R, Cheney H, Mindlin M. Do trusts ensure their workers are immune to measles, mumps, and rubella? BMJ. 2013;346:f3549. PubMed: www.amedeo.com/p2.php?id=23737267&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23737267

5. PRZEDPELSKI A, Tepp WH, Kroken AR, Fu Z, et al.

Enhancing the protective immune response against botulism. Infect Immun. 2013;81:2638-44. PubMed: www.amedeo.com/p2.php?id=23670557&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23670557

6. OTA T, Doyle-Cooper C, Cooper AB, Doores KJ, et al. B Cells from Knock-in Mice Expressing Broadly Neutralizing HIV Antibody b12 Carry an Innocuous B Cell Receptor Responsive to HIV Vaccine Candidates. J Immunol. 2013. PubMed: www.amedeo.com/p2.php?id=23940273&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23940273

8. KNUSCHKE T, Sokolova V, Rotan O, Wadwa M, et al. Immunization with Biodegradable Nanoparticles Efficiently Induces Cellular Immunity and Protects against Influenza Virus Infection. J Immunol. 2013. PubMed: www.amedeo.com/p2.php?id=23667109&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23667109

9. YAMADA M, Kamberos N, Grose C. Breakthrough Varicella in a Cancer Patient with Persistent Varicella Antibody after One Varicella Vaccination. J Pediatr. 2013 Aug 6. pii: S0022-3476(13)00802. PubMed: www.amedeo.com/p2.php?id=23932212&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23932212

10. EBERHARDT MK, Deshpande A, Chang WW, Barthold SW, et al. Vaccination Against a Virally-Encoded Cytokine Significantly Restricts Viral Challenge. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=23946461&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23946461

11. BRIEN JD, Sukupolvi-Petty S, Williams KL, Lam CY, et al. Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus. J Virol. 2013;87:7747-53. PubMed: www.amedeo.com/p2.php?id=23658441&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23658441

12. FIEDLER M, Kosinska A, Schumann A, Brovko O, et al. Prime/Boost Immunization with DNA and Adenoviral Vectors Protects from Hepatitis D Virus (HDV) Infection after Simultaneous Infection with HDV and Woodchuck Hepatitis Virus. J Virol. 2013. PubMed: www.amedeo.com/p2.php?id=23637419&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23637419

13. VORA NM, Basavaraju SV, Feldman KA, Paddock CD, et al. Raccoon rabies virus variant transmission through solid organ transplantation. JAMA. 2013;310:398-407. PubMed: www.amedeo.com/p2.php?id=23917290&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23917290

14. MSIMANG VM, Page N, Groome MJ, Moyes J, et al. Impact of Rotavirus Vaccine on Childhood Diarrheal Hospitalization Following Introduction into the South African Public Immunization Program. Pediatr Infect Dis J. 2013. PubMed: www.amedeo.com/p2.php?id=23934208&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23934208

16. STUMPF KA, Thompson T, Sanchez PJ. Rotavirus Vaccination of Very Low Birth Weight Infants at Discharge From the NICU. Pediatrics. 2013. PubMed: www.amedeo.com/p2.php?id=23940248&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23940248

17. FOUCHIER RA, Kawaoka Y, Cardona C, Compans RW, et al. Gain-of-function experiments on H7N9. Science. 2013;341:612-3. PubMed: www.amedeo.com/p2.php?id=23929965&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23929965

18. KAISER J. Infectious diseases. Unconventional vaccine shows promise against malaria. Science. 2013;341:605.

PubMed: www.amedeo.com/p2.php?id=23929962&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23929962

19. SEDER RA, Chang LJ, Enama ME, Zephir KL, et al. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine. Science. 2013. PubMed: www.amedeo.com/p2.php?id=23929949&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23929949

20. KUPFERSCHMIDT K. Infectious diseases. Bacterial meningitis finds new niche in gay communities. Science. 2013;341:328. PubMed: www.amedeo.com/p2.php?id=23888010&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23888010

21. DISTEFANO D, Antonello J, Bett A, Medi MB, et al. Immunogenicity of a reduced-dose whole killed rabies vaccine is significantly enhanced by ISCOMATRIX adjuvant, Merck amorphous aluminum hydroxylphosphate sulfate (MAA) or a synthetic TLR9 agonist in rhesus macaques. Vaccine. 2013 Aug 10. pii: S0264-410X(13)00977. PubMed: www.amedeo.com/p2.php?id=23941913&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23941913

22. DORNELES EM, de Faria AP, Pauletti RB, Santana JA, et al. Genetic stability of Brucella abortus S19 and RB51 vaccine strains by multiple locus variable number tandem repeat analysis (MLVA16). Vaccine. 2013 Aug 6. pii: S0264-410X(13)01049. PubMed: www.amedeo.com/p2.php?id=23933375&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933375

24. ZHANG M, Zhao L, Song J, Li Y, et al. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX that protect BALB/c mice against type II parasite infection. Vaccine. 2013 Aug 6. pii: S0264-410X(13)01051. PubMed: www.amedeo.com/p2.php?id=23933373&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933373

25. KAVANAGH K, Robertson C, McMenamin J. Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method-Experience across the 2010/11 season. Vaccine. 2013 Aug 6. pii: S0264-410X(13)01042. PubMed: www.amedeo.com/p2.php?id=23933371&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933371

26. KOS M, Locatelli I. Reply to response to Limitations of the study "Cost-effectiveness of tick-borne encephalitis vaccination in Slovenian adults" Vaccine. 2013 Aug 6. pii: S0264-410X(13)01047. PubMed: www.amedeo.com/p2.php?id=23933370&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23933370

27. VAN BUYNDER PG, Konrad S, Van Buynder JL, Brodkin E, et al. The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly. Vaccine. 2013 Aug 6. pii: S0264-410X(13)01045. PubMed: www.amedeo.com/p2.php?id=23933368&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933368

28. JONES C, Lee CK, Ahn C, Shin J, et al. Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012. Vaccine. 2013 Aug 6. pii: S0264-410X(13)01056. PubMed: www.amedeo.com/p2.php?id=23933367&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933367

29. CARDOSO SA, Oliveira AF, Ruas LP, Trevisani MM, et al. Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection. Vaccine. 2013 Aug 6. pii: S0264-410X(13)01053. PubMed: www.amedeo.com/p2.php?id=23933366&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933366

31. WIJESUNDARA DK, Jackson RJ, Tscharke DC, Ranasinghe C, et al. IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8 T cell avidity following HIV-1 recombinant pox viral vaccination.

Vaccine. 2013 Aug 6. pii: S0264-410X(13)01048. PubMed: www.amedeo.com/p2.php?id=23933364&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933364

32. MCCARNEY S, Robertson J, Arnaud J, Lorenson K, et al. Using solar-powered refrigeration for vaccine storage where other sources of reliable electricity are inadequate or costly. Vaccine. 2013 Aug 8. pii: S0264-410X(13)01067. PubMed: www.amedeo.com/p2.php?id=23933340&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933340

33. SCHERLIESS R, Buske S, Young K, Weber B, et al. In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations. Vaccine. 2013 Aug 8. pii: S0264-410X(13)01072. PubMed: www.amedeo.com/p2.php?id=23933339&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933339

34. JOSHI H, Lewis K, Singharoy A, Ortoleva PJ, et al. Epitope engineering and molecular metrics of immunogenicity: A computational approach to VLP-based vaccine design. Vaccine. 2013 Aug 8. pii: S0264-410X(13)01066. PubMed: www.amedeo.com/p2.php?id=23933338&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933338

35. TUMBAN E, Peabody J, Peabody DS, Chackerian B, et al. A universal virus-like particle-based vaccine for human papillomavirus: Longevity of protection and role of endogenous and exogenous adjuvants. Vaccine. 2013 Aug 8. pii: S0264-410X(13)01009. PubMed: www.amedeo.com/p2.php?id=23933337&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933337

37. GIBBONS RV, Nisalak A, Yoon IK, Tannitisupawong D, et al. A model international partnership for community-based research on vaccine-preventable diseases: The Kamphaeng Phet-AFRIMS Virology Research Unit (KAVRU). Vaccine. 2013 Aug 8. pii: S0264-410X(13)01073. PubMed: www.amedeo.com/p2.php?id=23933334&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933334

38. LI X, Galliher-Beckley A, Huang H, Sun X, et al. Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus. Vaccine. 2013 Aug 8. pii: S0264-410X(13)01071. PubMed: www.amedeo.com/p2.php?id=23933333&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933333

39. SHAFER LA, Jeffrey I, Elias B, Shearer B, et al. Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model. Vaccine. 2013 Aug 8. pii: S0264-410X(13)01064. PubMed: www.amedeo.com/p2.php?id=23933332&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23933332

40. GHOSH M, Solanki AK, Roy K, Dhoke RR, et al. Carrier protein influences immunodominance of a known epitope: Implication in peptide vaccine design. Vaccine. 2013 Aug 5. pii: S0264-410X(13)01010. PubMed: www.amedeo.com/p2.php?id=23928464&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23928464

41. MELAMED S, Wyatt LS, Kastenmayer RJ, Moss B, et al. Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants. Vaccine. 2013 Aug 5. pii: S0264-410X(13)01043. PubMed: www.amedeo.com/p2.php?id=23928462&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23928462

42. HECHTER RC, Tartof SY, Jacobsen SJ, Smith N, et al. Trends and disparity in zoster vaccine uptake in a managed care population. Vaccine. 2013 Aug 5. pii: S0264-410X(13)01011. PubMed: www.amedeo.com/p2.php?id=23928461&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23928461

43. ZHENG B, Lu S, Tong Q, Kong Q, et al. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice. Vaccine. 2013 Aug 5. pii: S0264-410X(13)01044. PubMed: www.amedeo.com/p2.php?id=23928460&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23928460

44. FU Q, Wei Z, Chen Y, Xiao P, et al. Identification of a surface protective antigen, CSP of Streptococcus equi ssp. zooepidemicus. Vaccine. 2013;31:1400-5. PubMed: www.amedeo.com/p2.php?id=23306366&s=vac&pm=badc2a9eebb0fad

ABSTRACT available Share: http://m.amedeo.com/23306366

45. DODET B, Korejwo J, Briggs DJ. Eliminating the scourge of dog-transmitted rabies. Vaccine. 2012 Dec 29. pii: S0264-410X(12)01611. PubMed: www.amedeo.com/p2.php?id=23280358&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23280358

46. OOMS K, Van Gorp H, Botti S, Van Gaever T, et al. Evaluation of viral peptide targeting to porcine sialoadhesin using a porcine reproductive and respiratory syndrome virus vaccination-challenge model. Virus Res. 2013 Aug 8. pii: S0168-1702(13)00261. PubMed: www.amedeo.com/p2.php?id=23932898&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23932898

PATENTES

United States Patent and Trademark Office (USPTO)

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20130813->20130823): 7 patentes recuperadas.

Adyuvantes

4 8,506,971 Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria

Vacunas, otras

PAT. NO. TITLE

1 8,512,709 Modified amyloid .beta. peptide

2 8,512,703 Idiotypic vaccine

3 8,507,278 Live attenuated catfish vaccine and method of making

4 8,506,971 Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria

5 8,506,969 Efficient cell culture system for hepatitis C virus genotype 7a

6 8,506,968 SARS vaccine compositions and methods of making and using them

7 8,506,966 Adjuvanted influenza vaccines for pediatric use

European Patent Office (EPO) Acumulado entre el 13 y el 23 de agosto de 2013: 22 patentes recuperadas.

1. DNA VACCINE BASED ON B7-1-PE40KDEL EXOTOXIN FUSION GENE AND USE THEREOF

Applicant: Inventor: IPC: Priority AFFILIATED CPC: Publication info: XI YONGZHI A61K48/00 date: HOSPITAL OF [CN] C07K14/21 A61P37/06 EP2628802 (A1) ACADEMY OF 2011- LUO YUAN C07K14/70532 C07K19/00 2013-08-21 MILITARY MEDICAL 01-14 [CN] (+2) SCIENCES PLA [CN] 2. NOROVIRUS CAPSID AND ROTAVIRUS VP6 PROTEIN FOR USE AS COMBINED VACCINE

Inventor: CPC: IPC: Priority VESIKARI Applicant: Publication info: A61K39/125 A61K39/125 date: TIMO [FI] VESIKARI TIMO [FI] A61K39/15 A61K39/15 EP2627353 (A1) BLAZEVIC 2010- BLAZEVIC VESNA [FI] A61K39/295 A61K39/295 2013-08-21 VESNA [FI] 10-14 (+7) (+4) (+4) 3. RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) INFLUENZA VACCINE

Inventor: CPC: Priority WEIGL JOSEF Applicant: Publication info: A61K2039/5254 IPC: date: [DE] BAVARIAN NORDIC A61K2039/5256 EP2627774 (A2) STEIGERWALD C12N15/863 2010- AS [DK] A61K2039/545 2013-08-21 ROBIN [DE] 10-15 (+6) (+1) 4. MUC1 based glycolipopeptide vaccine with adjuvant

Inventor: IPC: CPC: Priority Publication info: PETERSON Applicant: A61K39/00 date: A61K9/0019 SCOTT A61K39/395 AU2012222188 (A1) ONCOTHYREON INC A61K9/127 2011- MILLARD A61K9/127 2013-08-15 A61K9/1271 02-24 JEFFREY (+4) (+3) 5. Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the

same, and methods of use thereof

Inventor: CPC: Priority Publication info: WEINER Applicant: A61K2039/53 IPC: date: DAVID B A61K39/245 AU2012212264 (A1) UNIV PENNSYLVANIA A61K48/00 2011- SHEDLOCK C07K14/005 2013-08-15 01-31 DEVON J (+4) 6. NUCLEIC ACID MOLECULE ENCODING HEPATITIS B VIRUS CORE PROTEIN AND SURFACE ANTIGEN PROTEIN AND VACCINE COMPRISING THE SAME

Inventor: IPC: Applicant: Priority Publication info: WEINER A61K39/29 date: WEINER DAVID B CPC: DAVID B [US] A61P31/20 US2013209395 (A1) [US] 2012- YAN JIAN [US] A61P37/04 2013-08-15 YAN JIAN [US] (+1) 02-13 (+1) (+4) 7. COMPOSITIONS, METHODS AND USES FOR POXVIRUS ELEMENTS IN VACCINE CONSTRUCTS AGAINST INFLUENZA VIRUS SUBTYPES OR STRAINS

Inventor: Applicant: CPC: Priority STINCHCOMB Publication info: STINCHCOMB DAN T A61K2039/5256 IPC: date: DAN T [US] [US] A61K39/00 US2013209513 (A1) OSORIO C12N15/863 2009- OSORIO JORGE E A61K39/12 2013-08-15 JORGE E [US] 11-20 [US] (+3) (+3) (+3) 8. PROLIFERATING AGENT FOR MONOCYTE, CULTURE MEDIUM FOR PROLIFERATING MONOCYTE, METHOD FOR PRODUCING MONOCYTE, METHOD FOR PRODUCING DENDRITIC CELL, AND METHOD FOR PRODUCING DENDRITIC CELL VACCINE

Inventor: Applicant: IPC: Priority Publication info: ABE HAKUSHINKOUSEIKAI A61K39/00 date: CPC: HIROYUKI [JP] FOUNDATION [JP] A61P35/00 WO2013118899 (A1) 2012- KAWASAKI LIFE SCIENCE RES C12N5/0784 2013-08-15 02-10 HIROAKI [JP] INST LTD [JP] (+1) 9. SHEEP NEMATODE VACCINE

Inventor: IPC: Priority Applicant: CPC: Publication info: MATTHEWS A61K39/00 date: JACQUELINE MOREDUN RES INST A61K39/0003 C07K14/435 WO2013117912 (A1) 2012- [GB] [GB] C07K14/43536 C07K16/00 2013-08-15 02-07 NISBET (+1) 38

ALASDAIR [GB] (+1) 10. COMBINED ANTIGEN AND DNA VACCINE FOR PREVENTING AND TREATING RSV INFECTION

Inventor: Applicant: IPC: Priority Publication info: WANG BIN BEIJING ADVACCINE A61K39/155 date: CPC: [CN] BIOTECHNOLOGY CO A61K48/00 WO2013116965 (A1) 2012- CHEN XUAN LTD [CN] A61P31/14 2013-08-15 02-10 [CN] (+1) WANG BIN [CN] (+2) (+2) 11. ORAL VACCINE FAST-DISSOLVING DOSAGE FORM USING STARCH

Inventor: CPC: Applicant: IPC: Priority Publication info: TIAN WEI A61K2039/55583 date: R P SCHERER A61K39/145 [GB] A61K2039/6087 EP2624815 (A1) TECHNOLOGIES LLC A61K47/36 2010- MCLAUGHLIN A61K39/145 2013-08-14 [US] A61K9/00 10-08 ROSIE [GB] (+6) 12. MALARIA VACCINE

Inventor: Priority WRIGHT Applicant: IPC: Publication info: CPC: date: GAVIN J [GB] GENOME RES LTD A61K39/015 EP2624861 (A1) RAYNER A61K39/015 2010- [GB] C07K16/20 2013-08-14 JULIAN C [GB] 10-08 (+3)

Vacunas, otras

1. DNA VACCINE BASED ON B7-1-PE40KDEL EXOTOXIN FUSION GENE AND USE THEREOF

2. NOROVIRUS CAPSID AND ROTAVIRUS VP6 PROTEIN FOR USE AS COMBINED VACCINE

Inventor: Applicant: CPC: IPC: Publication info: Priority date: VESIKARI VESIKARI TIMO [FI] A61K39/125 A61K39/125 EP2627353 (A1) TIMO [FI] BLAZEVIC VESNA [FI] A61K39/15 A61K39/15 2013-08-21 2010-

BLAZEVIC A61K39/295 A61K39/295 10-14 VESNA [FI] (+7) (+4) (+4)

3. RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) INFLUENZA VACCINE

4. MUC1 based glycolipopeptide vaccine with adjuvant

5. Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof

6. NUCLEIC ACID MOLECULE ENCODING HEPATITIS B VIRUS CORE PROTEIN AND SURFACE ANTIGEN PROTEIN AND VACCINE COMPRISING THE SAME

Inventor: IPC: Applicant: Priority Publication info: WEINER A61K39/29 date: WEINER DAVID B CPC: DAVID B [US] A61P31/20 US2013209395 (A1) [US] 2012- YAN JIAN A61P37/04 2013-08-15 YAN JIAN [US] (+1) 02-13 [US] (+1) (+4)

7. COMPOSITIONS, METHODS AND USES FOR POXVIRUS ELEMENTS IN VACCINE CONSTRUCTS AGAINST INFLUENZA VIRUS SUBTYPES OR STRAINS

8. PROLIFERATING AGENT FOR MONOCYTE, CULTURE MEDIUM FOR PROLIFERATING MONOCYTE, METHOD FOR PRODUCING MONOCYTE, METHOD FOR PRODUCING DENDRITIC CELL, AND METHOD FOR PRODUCING DENDRITIC CELL VACCINE

Inventor: Applicant: IPC: Priority ABE Publication info: HAKUSHINKOUSEIKAI A61K39/00 date: HIROYUKI CPC: FOUNDATION [JP] A61P35/00 WO2013118899 (A1) [JP] 2012- LIFE SCIENCE RES C12N5/0784 2013-08-15 KAWASAKI 02-10 INST LTD [JP] (+1) HIROAKI [JP]

9. SHEEP NEMATODE VACCINE

Inventor: IPC: MATTHEWS Priority Applicant: CPC: Publication info: JACQUELINE A61K39/00 date: [GB] MOREDUN RES INST A61K39/0003 C07K14/435 WO2013117912 (A1) 2012- NISBET [GB] C07K14/43536 C07K16/00 2013-08-15 02-07 ALASDAIR (+1) [GB] (+1)

10. COMBINED ANTIGEN AND DNA VACCINE FOR PREVENTING AND TREATING RSV INFECTION

11. ORAL VACCINE FAST-DISSOLVING DOSAGE FORM USING STARCH

12. MALARIA VACCINE

Inventor: Priority WRIGHT Applicant: IPC: Publication info: CPC: date: GAVIN J [GB] GENOME RES LTD A61K39/015 EP2624861 (A1) RAYNER A61K39/015 2010- [GB] C07K16/20 2013-08-14 JULIAN C [GB] 10-08 (+3)

